Olfactory identification and cognitive performance in community-dwelling older adults with mild cognitive impairment

Chemical Senses

Volumn 39, Issue 1, 2014, Pages 39-46

  Makizako, Mihoko ^a   Makizako, Hyuma ^b,c   Doi, Takehiko ^b   Uemura, Kazuki ^b,c   Tsutsumimoto, Kota ^b   Miyaguchi, Hideki ^d   Shimada, Hiroyuki ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cognitive functioning; Memory; Olfactory identification

Indexed keywords

AGE DISTRIBUTION; AMNESIA; ARTICLE; BAGED; BFEMALE; BHUMAN; BMAJOR CLINICAL STUDY; BMALE; COGNITION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; HYPOSMIA; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGY; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; SEX DIFFERENCE; SMELLING; SMELLING DISORDER; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

COGNITIVE FUNCTIONING; MEMORY; OLFACTORY IDENTIFICATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; FEMALE; HUMANS; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; ODORS; OLFACTION DISORDERS;

EID: 84890837185     PISSN: 0379864X     EISSN: 14643553     Source Type: Journal    
DOI: 10.1093/chemse/bjt052     Document Type: Article

References (56)

1. Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S, Hasegawa T, Sugeno N, Konno M, Suzuki K, et al. 2012. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain. 135:161-169.
2. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:239-259.
3. Braak H, Braak E. 1997. Staging of Alzheimer-related cortical destruction. Int Psychogeriatr. 9(Suppl 1):257-261; discussion 269-272.
4. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 24:197-211.
5. Busse A, Hensel A, Gühne U, Angermeyer MC, Riedel-Heller SG. 2006. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology. 67:2176-2185.
6. Chetelat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, et al. 2011. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain. 134:798-807.
7. Devanand DP, Bansal R, Liu J, Hao X, Pradhaban G, Peterson BS. 2012. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. Neuroimage. 60:1622-1629.
8. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH. 2008. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry. 64:871-879.
9. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R. 2000. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry. 157:1399-1405.
10. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, et al. 2007. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology. 68:828-836.
11. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. 2008. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 29:693-706.
12. Doty RL, Reyes PF, Gregor T. 1987. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 18:597-600.
13. Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearelli S, Mina C, Amabile G, Fusetti M. 2005. Olfactory screening test in mild cognitive impairment. Neurol Sci. 26:156-160.
14. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:189-198.
15. Fusetti M, Fioretti AB, Silvagni F, Simaskou M, Sucapane P, Necozione S, Eibenstein A. 2010. Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment. J Otolaryngol Head Neck Surg. 39:175-181.
16. Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg GD, Larson EB. 1999. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology. 53:1480-1487.
17. Haxby JV, Petit L, Ungerleider LG, Courtney SM. 2000. Distinguishing the functional roles of multiple regions in distributed neural systems for visual working memory. Neuroimage. 11:145-156.
18. Higuchi S, Liu Y, Yuasa T, Maeda A, Motohashi Y. 2000. Diurnal variation in the P300 component of human cognitive event-related potential. Chronobiol Int. 17:669-678.
19. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E. 1999. Prediction of AD with MRIbased hippocampal volume in mild cognitive impairment. Neurology. 52:1397-1403.
20. Kaplan RJ, Greenwood CE, Winocur G, Wolever TM. 2000. Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates. Am J Clin Nutr. 72:825-836.
21. Kesslak JP, Nalcioglu O, Cotman CW. 1991. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 41:51-54.
22. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS. 2002. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 58:1188-1196.
23. Kjelvik G, Evensmoen HR, Brezova V, Håberg AK. 2012. The human brain representation of odor identification. J Neurophysiol. 108:645-657.
24. Kobayashi M, Saito S, Kobayakawa T, Deguchi Y, Costanzo RM. 2006. Cross-cultural comparison of data using the odor stick identification test for Japanese (OSIT-J). Chem Senses. 31:335-342.
25. Levey A, Lah J, Goldstein F, Steenland K, Bliwise D. 2006. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. Clin Ther. 28:991-1001.
26. Lezak M. 2004. Neuropsychological assessment. New York: Oxford University Press.
27. Lotsch J, Nordin S, Hummel T, Murphy C, Kobal G. 1997. Chronobiology of nasal chemosensitivity: do odor or trigeminal pain thresholds follow a circadian rhythm? Chem Senses. 22:593-598.
28. Mackay-Sim A, Johnston AN, Owen C, Burne TH. 2006. Olfactory ability in the healthy population: reassessing presbyosmia. Chem Senses. 31:763-771.
29. Makizako H, Shimada H, Park H, Doi T, Yoshida D, Uemura K, Tsutsumimoto K, Suzuki T. 2013. Evaluation of multi-dimensional neurocognitive function using a tablet PC: test-retest reliability and validity in communitydwelling older adults. Geriatr Gerontol Int. 13:860-866.
30. McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD. 2001. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry. 70:739-743.
31. Mitchell AJ, Bird V, Rizzo M, Meader N. 2010. Diagnostic validity and added value of the Geriatric Depression Scale for depression in primary care: a meta-analysis of GDS30 and GDS15. J Affect Disord. 125:10-17.
32. Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. 1999. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 158:469-490.
33. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. 2002. Prevalence of olfactory impairment in older adults. JAMA. 288:2307-2312.
34. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, et al. 2012. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 71:362-381.
35. Okutani F, Hirose K, Kobayashi T, Kaba H, Hyodo M. 2013. Evaluation of "Open Essence" odor-identification test card by application to healthy volunteers. Auris Nasus Larynx. 40:76-80.
36. Petersen RC. 2004. Mild cognitive impairment as a diagnostic entity. J Intern Med. 256:183-194.
37. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. 2001. Current concepts in mild cognitive impairment. Arch Neurol. 58:1985-1992.
38. Petersen RC, Knopman DS. 2006. MCI is a clinically useful concept. Int Psychogeriatr. 18:394-402; discussion 409-414.
39. Rey A. 1958. L'éxamen clinique en psychologie. Paris (France): Press Universitaire de France.
40. Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, Johnson SC. 2008. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc. 56:920-934.
41. Royall DR, Chiodo LK, Polk MS, Jaramillo CJ. 2002. Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology. 21:68-73.
42. Saito S, Ayabe-Kanamura S, Takashima Y, Gotow N, Naito N, Nozawa T, Mise M, Deguchi Y, Kobayakawa T. 2006. Development of a smell identification test using a novel stick-type odor presentation kit. Chem Senses. 31:379-391.
43. Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. 2008. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc. 56:1517-1521.
44. Serby M, Larson P, Kalkstein D. 1991. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry. 148:357-360.
45. Shimada H, Makizako H, Doi T, Yoshida D, Tsutsumimoto K, Anan Y, Uemura K, Ito T, Lee S, Park H, et al. 2013. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. J Am Med Dir Assoc. 14:518-524.
46. Spulber G, Niskanen E, Macdonald S, Kivipelto M, Padilla DF, Julkunen V, Hallikainen M, Vanninen R, Wahlund LO, Soininen H. 2012. Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD. Curr Alzheimer Res. 9:516-524.
47. Stafford LD, Welbeck K. 2011. High hunger state increases olfactory sensitivity to neutral but not food odors. Chem Senses. 36:189-198.
48. Swan GE, Carmelli D. 2002. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology. 21:58-67.
49. Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP. 2005. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol. 58:155-160.
50. Tapiola T, Pennanen C, Tapiola M, Tervo S, Kivipelto M, Hänninen T, Pihlajamäki M, Laakso MP, Hallikainen M, Hämäläinen A, et al. 2008. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study. Neurobiol Aging. 29:31-38.
51. Teixeira CV, Gobbi LT, Corazza DI, Stella F, Costa JL, Gobbi S. 2012. Nonpharmacological interventions on cognitive functions in older people with mild cognitive impairment (MCI). Arch Gerontol Geriatr. 54:175-180.
52. Wechsler D. 1981. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation.
53. Wechsler D. 1987. Wechsler Memory Scale-Revised Manual. San Antonio (TX): The Psychological Corporation.
54. Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. 2007. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 78:30-35.
55. Wilson RS, Arnold SE, Tang Y, Bennett DA. 2006. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology. 26:61-67.
56. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. 2007. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 64:802-808.